CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...
CHICAGO--(BUSINESS WIRE)--Contrast enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for finding ...
CHICAGO, September 10, 2025--(BUSINESS WIRE)--A new study shows that contrast enhanced ultrasound (CEUS) techniques offer an encouraging option for noninvasively detecting pancreatic cancer in its ...
A comprehensive new study based on nationwide claims data from more than 11 million patients shows that diagnostic contrast-enhanced ultrasound (CEUS) exams are safe and can lower a patient’s risk of ...
CHICAGO, September 10, 2025--(BUSINESS WIRE)--Two new clinical trials show that microbubble ultrasound contrast agents safely and effectively improve liver tumor responses to radiotherapy and patient ...
In most cases, the targeted microbubble contrast agents (MCAs) are fitted with a high-affinity targeting ligand. After the MCAs are adhered to the target, they begin to improve the acoustic signal ...
The published dosing standards set the drug-delivery technology on a path toward FDA consideration and eventual use against ...
Supplementary contrast imaging detected more breast cancers than automated whole-breast ultrasound in women with dense breasts. The invasive tumor size found by abbreviated MRI and contrast-enhanced ...
A new study has identified sonographic biomarkers that can predict eventual malignant transformation of pathologically confirmed cirrhotic nodules for patients at risk for hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback